ABSTRACT
BACKGROUND:Studies have shown that tumor stem ceils are the basis and the main cause of tumor recurrence and chemotherapy failure.Therefore,the research on the drug resistance of tumor stem cells has become a hotspot in the field of stem cell research.OBJECTIVE:To analyze the biological characteristics of side population (SP) cells in the U266 cell lines in relation to drug resistance.METHODS:Flow cytometry was used to monitor the percentage of SP cells in the U266 cell lines.Fluorescence-activated cell sorter (FACS) analysis was used to isolate SP and non-SP (NSP) cells from the U266 cell lines.Further analyses of the cell cycle,multidrug resistant protein,methyl cellulose cloning assay of SP cells and NSP cells were performed.Real-time quantitative PCR was used to determine the expression of ABCG2 and MDR1 genes.RESULTS AND CONCLUSION:There were (2.46±0.35)％ SP cells in U266 cells,which were most in the G0 phase.The ratio of G0/G1 in SP cells was (81.50±5.42)％,which was significantly higher than that in NSP cells [(39.85±3.21)％;P ＜0.05].The positive expression rates of P-gp and ABCG2 in SP cells were signficantly higher than those in NSP cells (P ＜0.05).The cloning efficiency of SP cells was significantly higher than that of NSP cells (P ＜ 0.05).The mRNA expression of ABCG2 and MDR1 was also significantly higher in SP cells than in NSP cells (P ＜ 0.05).To conclude,a small subpopulation of the isolates of U266 cell lines belong to tumor stem cell-like SP cell subset,most of which are at the G0 phase.ABCG2 and MDR1 genes are highly expressed in SP cells,which particularly plays a important role in the multidrug resistance of multiple myeloma stem cell lines.
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the applicability of immune-related response criteria (irRC) in treating non-small cell lung cancer (NSCLC) by Chinese medicine (CM).</p><p><b>METHODS</b>Totally 97 stage III a-IV NSCLC patients were predominantly treated with comprehensive CM. Curative effects were evaluated by three methods such as Response Evaluation Criteria in Solid Tumors (RECIST), Oncologic Curative Effect Evaluation Criteria of Chinese Medicine in Solid Tumor (draft, abbreviated as CM criteria), and irRC. The correspondency and consistency between irRC, RECIST and CM criteria were analyzed and compared. The objectivity of irRC in evaluating curative effect of Chinese medical treatment for NSCLC was assessed.</p><p><b>RESULTS</b>The correspondency rate of irRC to RECIST was 59. 79% with Kappa value of 0. 379 (U test, P <0. 01). The two criteria had certain correspondence, but with an unsatisfactory consistency. The correspondency rate of irRC to CM criteria rate was 83. 51% with Kappa value of 0.751 (U test, P <0. 01). The two criteria had good correspondence and consistency.</p><p><b>CONCLUSIONS</b>CM criteria had good consistency with CM criteria in evaluating curative effect for Chinese medical treatment of advanced NSCLC. Its results could objectively reflect features and advantages of CM for treating advanced NSCLC.</p>
Subject(s)
Humans , Asian People , Carcinoma, Non-Small-Cell Lung , Drug Therapy , Allergy and Immunology , Drugs, Chinese Herbal , Therapeutic Uses , Lung Neoplasms , Drug Therapy , Allergy and Immunology , Medicine, Chinese Traditional , Reference Standards , Treatment OutcomeABSTRACT
<p><b>BACKGROUND</b>Surgical treatment of intracranial aneurysms is often compromised by incomplete exclusion of the aneurysm or stenosis of parent vessels. Intraoperative microvascular Doppler (IMD) is an attractive, noninvasive, and inexpensive tool. The present study aimed to evaluate the usefulness and reliability of IMD for guiding clip placement in aneurysm surgery.</p><p><b>METHODS</b>A total of 92 patients with 101 intracranial aneurysms were included in the study. IMD with a 1.5-mm diameter, 20-MHz microprobe was used before and after clip application to confirm aneurysm obliteration and patency of parent vessels and branching arteries. IMD findings were verified postoperatively with digital subtraction angiography (DSA) or dual energy computed tomography angiography (DE-CTA). Ninety consecutive patients, harboring 108 aneurysms, who underwent surgery without IMD was considered as the control group.</p><p><b>RESULTS</b>The microprobe detected all vessels of the Circle of Willis and their major branches. Clips were repositioned in 24 (23.8%) aneurysms on the basis of the IMD findings consistent with incomplete exclusion and/or stenosis. IMD identified persistent weak blood flow through the aneurismal sac of 11 of the 101 (10.9%) aneurysms requiring clip adjustment. Stenosis or occlusion of the parent or branching arteries as indicated by IMD necessitated immediate clip adjustment in 19 aneurysms (18.8%). The mean duration of the IMD procedure was 4.8 minutes. The frequency of clip adjustment (mean: 1.8 times per case) was associated with the size and location of the aneurysm. There were no complications related to the use of IMD, and postoperative angiograms confirmed complete aneurysm exclusion and parent vessel patency. About 8.3% (9/108) aneurysms were unexpectedly incompletely occluded, and 10.2% (11/108) aneurysms and parent vessel stenosis without IMD were detected by postoperative DSA or DE-CTA. IMD could reduce the rate of residual aneurysm and unanticipated vessel stenosis which demonstrated statistically significant advantages compared with aneurysm surgery without IMD.</p><p><b>CONCLUSION</b>IMD is a safe, easily performed, reliable, and valuable tool that is suitable for routine use in intracranial surgery, especially in complicated, large, and giant aneurysms with wide neck or without neck.</p>